Navigation Links
Roche purchases innovative nucleic acid purification technology from Lumora to enhance sample preparation for sequencing
Date:8/24/2015

PLEASANTON, Calif., Aug. 24, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) has signed a definitive asset purchase agreement with Lumora for products associated with the unique, patent-protected Heat Elution1 technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded (FFPE) tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution.

Today, nucleic acid purification technology from specimens including formalin-fixed tissues can be cumbersome and inefficient. Lumora's highly differentiated proprietary methodology will enable simple and automated nucleic acid isolation in minutes instead of hours. In addition, the technology is environmentally friendly and can be applied to process a wide variety of sample types including whole blood, fecal matter, sputum, FFPE tissue and buccal swabs.

"Lumora's Heat Elution technology can be integrated to an automated sequencing workflow, which makes it an ideal fit for Roche's sequencing vision of a sample-in–results-out workflow," said Dan Zabrowski, Head of Roche Tissue Diagnostics and Roche Sequencing Unit.

"An important bottleneck in sequencing workflow is nucleic acid extraction. Heat Elution technology significantly simplifies extraction and is simple to automate. The acquisition of this technology may offer Roche a unique position in fully integrated sequencing devices," said Laurence Tisi, CEO, Lumora.

1 For Research Use Only. Not for use in diagnostic procedures.

About Lumora

Lumora is a successful provider of state-of-the-art molecular diagnostic products in the clinical, non-clinical and industrial markets. Lumora's easy to deploy and use technology can be employed in fields as diverse as food safety testing and medical diagnostics. The Company is active in commercialising its technology and its development and commercialisation partners include international biotechnology, clinical diagnostic and industrial microbiology companies.

Lumora's corporate office is based just outside of Cambridge, England. www.lumora.co.uk

About Roche 

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com. All trademarks used or mentioned in this release are protected by law.

For further information please contact: 

Roche Sequencing Media Relations
Jacquie Bucher
Phone: +1 520.468.9145
Email: jacquie.bucher@roche.com


'/>"/>
SOURCE Roche
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Digital PCR (dPCR) and qPCR Market to 2019 - With Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc and F. Hoffmann-La Roche Ltd Dominating the Market
2. Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy
3. Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo
4. Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas - Key Players are Roche, BMS, Sanofi, GSK, Boehringer Ingelheim, Celgene, Novartis and Pfizer
5. Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment
6. Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab
7. Guardant Health Appoints Mort Minaee, Former Roche Senior Director, as VP of Regulatory Affairs
8. Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche
9. Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating
10. System-wide standardization of laboratory testing with new Roche technology to offer patient, people and process benefits for BJC HealthCare
11. Rochester Drug Cooperative and Aureus Health Services Announce the Launch of a Specialty Pharmacy Management Program for Independent Retail Pharmacies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2020)... ... August 28, 2020 , ... Dr. Raheleh Sarbaziha has been ... and approach. Armed with her qualifications from Ross University School of Medicine and ... the human body with the nation and world. With a fellowship in Integrative ...
(Date:8/27/2020)... ... August 27, 2020 , ... The flu season is right round the corner and ... equipped with all the necessary measures before it begins to harbor its effects on us. ... it is leaving a huge impact on our lives. Hence it has become even more ...
(Date:8/27/2020)... MYERS, Fla. (PRWEB) , ... August 27, 2020 , ... ... Board of Directors. Dr. Friedman is an adult and pediatric neuro-oncologist who serves on ... University and as an educator at Duke University Medical School. , Internationally recognized, Dr. ...
Breaking Medicine Technology:
(Date:8/31/2020)... ... 31, 2020 , ... Dr. Chang has over 20 years ... other developmental disabilities, as well as supporting staff in caring for patients and ... consultation, and staff development. She joined the company in 2015 as Chief of ...
(Date:8/28/2020)... ... 28, 2020 , ... Ernst & Young LLP (EY US) ... Of The Year® 2020 Florida Award finalist. Now in its 34th year, the ... growth and prosperity as they build and sustain successful businesses that transform our ...
(Date:8/28/2020)... ... August 28, 2020 , ... With in-person gluten-free events being ... helping the specialty-diet community connect with great, gluten-free brands. At the Online ... chat with brands & watch over 50 educational classes... all online from the ...
(Date:8/28/2020)... ... August 28, 2020 , ... A ... suggest that obese individuals are at an increased risk of developing severe COVID-19 ... to catch COVID-19; however, because the same organ systems that the coronavirus attacks ...
(Date:8/27/2020)... ... August 27, 2020 , ... Evolution Labs ... to provide their students with Suite360:Mental Health and Prevention, a program developed to ... and Child Trafficking Prevention. , Florida schools and districts must provide their students ...
Breaking Medicine News(10 mins):